Navigation Links
Collagen Matrix, Inc. Receives FDA 510(k) Clearance for TenoMend(TM) Collagen Tendon Wrap for the Management and Protection of Tendon Injuries
Date:5/27/2008

FRANKLIN LAKES, N.J., May 27 /PRNewswire/ -- Collagen Matrix, Inc. announced today that it has received the United States Food and Drug Administration's 510(k) clearance of its TenoMend(TM) Collagen Tendon Wrap indicated for the management and protection of tendon injuries in which there has been no substantial loss of tendon tissue.

TenoMend(TM) Collagen Tendon Wrap is a resorbable type 1 collagen matrix that provides a non-constricting encasement for injured tendons. TenoMend(TM) Collagen Tendon Wrap is designed to be an interface between the tendon and tendon sheath or the surrounding tissue. When hydrated, TenoMend(TM) Collagen Tendon Wrap is a conformable, nonfriable, self-curling collagen sheet designed for easy placement under, around or over the injured tendon. The patented self-curling wrap design offers the ability to implant with minimal suturing. The device provides a protected environment and gliding surface of the sheath for tendon healing.

In trauma cases, fractures and injuries of bones in the extremities typically result in injury of the associated soft tissue such as tendon and peripheral nerves. Tendon scarring can often occur as a result of tendon repair. When tendon scarring occurs, other structures such as joints may lose normal range of motion.

Collagen Matrix's portfolio of orthopaedic products now includes solutions for bone, tendon, and peripheral nerve repair. With Collagen Matrix's OssiGuide(TM) Cancellous Granules, OssiMend(TM) and OssiMend(TM) Putty Mineral-Collagen Composites, OssiPatch(TM) Bone Healing Protective Sheet, NeuroMatrix(TM) Collagen Nerve Conduit, Neuroflex(TM) Flexible Collagen Nerve Conduit, NeuroMend(TM) Collagen Nerve Wrap and TenoMend(TM) Collagen Tendon Wrap, the surgeon is equipped with the products needed to repair a complex injury.

The results of an animal flexor tendon repair study using TenoMend(TM) Collagen Tendon Wrap demonstrated the ease of implantation with the tendon's re
'/>"/>

SOURCE Collagen Matrix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Galderma Completes Acquisition of CollaGenex
2. Investor Alert from Cauley Bowman Carney & Williams, PLLC: Update on Proposed Acquisition of CollaGenex Pharmaceuticals, Inc. - CGPI
3. Collagen Matrix, Inc. Launches OssiMend(TM) Bone Graft Matrix for Orthopedic and Spine Applications
4. TEI Biosciences Launches SurgiMend(TM) Collagen Matrix for Soft Tissue Reconstruction
5. Jarrow Formulas Launches New Products Featuring BioCell Collagen II(R)
6. Organogenesis, Inc. Announces Acquisition of NanoMatrix, Inc.
7. BMP Sunstone Receives Import Drug License (IDL) from SFDA
8. Nikon Instruments Receives Record Number of Entries for Nikon Small World
9. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
10. febit Receives U.S. Patent for Microfluidic Extraction Method
11. Prime Therapeutics Receives VIPPS Accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)HOUSTON, Dec. 3 JourneyLite of Houston, LLC announced today that it has updated its facility to offer patients a second surgical option, vertical sleeve gastrectomy , along with the LAP-BAND®
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
...VLP vaccine trial enrollment positions Company to ... this year, ROCKVILLE, Md., Sept. 19 Novavax, In...ed enrollment of healthy,volunteers in a Phase IIa...ased seasonal influenza vaccine. The Phase IIa ran...uating the safety and immunogenicity of,different ...
...mber 19 Thirty seven medical,experts in psychiatr...,community to take urgent action to optimize servi...llness such as schizophrenia or bipolar,disorder(i...l author of Comorbid,Somatic Illnesses in Patients...d Research Challenges which was published in the J...
...os, Inc. (Amex: NEP ),today announced that the Co...erican Stock Exchange (AMEX) indicating that the C...s of the continued listing standards of,Section 10...oted the,Company,s failure to comply with Section ... stockholders, equity of less than $6,000,000 and ...
Other Biology Technology:Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial 2Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial 3Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial 4Global Psychiatrists Unite to Improve Services in Mental Health 2Global Psychiatrists Unite to Improve Services in Mental Health 3Nephros Receives Non-Compliance Notification from AMEX 2Nephros Receives Non-Compliance Notification from AMEX 3
(Date:12/3/2009)The extinction of plant and animal species can be likened to emptying a museum of its collection, or dumping a cabinet full of potential medicines into the trash, or replacing every local cuisine with
(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b
(Date:12/3/2009)Forest dwellers must be included in the design of the upcoming forest deal at Copenhagen in order to avoid a humanitarian crisis, according to a scientist at the University of Leeds. , Writing today
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Forest deal at Copenhagen must avoid creating 'carbon refugees' 2SETO Holdings Inc Enters Into Two Additional Leases for Two New Hearing Centers in Maryland and Virginia 52734 1SETO Holdings Inc Enters Into Two Additional Leases for Two New Hearing Centers in Maryland and Virginia 52734 2OrthoDynamix LLC Launches ArthroSteer 28TM 29 3A Reaching New Limits in Arthroscopy 52732 1OrthoDynamix LLC Launches ArthroSteer 28TM 29 3A Reaching New Limits in Arthroscopy 52732 2Solace Pharmaceuticals Appoints Professor David Julius Renowned Pain Physiologist to Scientific Advisory Board 13196 1Solace Pharmaceuticals Appoints Professor David Julius Renowned Pain Physiologist to Scientific Advisory Board 13196 2Solace Pharmaceuticals Appoints Professor David Julius Renowned Pain Physiologist to Scientific Advisory Board 13196 3
... has received a six-year contract from the U.S. Na...for the AN/UYQ-70 (Q-70) Advanced Display System. ...pport at over $13 million a year for the first two...he next four years, bringing the total potential c...ollows a recently awarded $525.6 million modificat...
...s and bumble bees are predictable in the way they ... one flower to an adjacent cluster of flowers in t... a direct affect on their ability to hunt for poll...d production that results when pollen moves from o...perienced more attention in part due to the recent...
...suffering from a blood disorder that prevents prop...at may dramatically improve their health. There ar...iduals in the U.S. diagnosed with chronic immune t...se that dramatically reduces the number of platele...nd, rarely, life-threatening brain hemorrhages. ,...
Other Biology News:U.S. Navy Awards Lockheed Martin Six-year Contract Worth Up to $72 Million for Advanced Display Systems Support 2Flight of the bumble (and honey) bee 2Lancet study supports new, highly effective treatment for blood disorder 2Lancet study supports new, highly effective treatment for blood disorder 3
Corning Culture Flask, 25 cm2, Tc-Treated, Angled Neck, Phenolic-Style Cap, Sterile from Sigma-Aldrich
LIC Duet™ T7•Tag® Ek Adaptor from Novagen
Corning Culture Flask, 75 cm2, Tc-Treated, Straight Neck, Phenolic-Style Cap, Sterile from Sigma-Aldrich
Mouse Anti-Human QARS Monoclonal Antibody, Unconjugated, Clone 5F5 from Novus Biologicals
Biology Products: